Fingerprint Dive into the research topics of 'RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically